Correlation Between Regenxbio and Celldex Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regenxbio and Celldex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenxbio and Celldex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regenxbio and Celldex Therapeutics, you can compare the effects of market volatilities on Regenxbio and Celldex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenxbio with a short position of Celldex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenxbio and Celldex Therapeutics.

Diversification Opportunities for Regenxbio and Celldex Therapeutics

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between Regenxbio and Celldex is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Regenxbio and Celldex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celldex Therapeutics and Regenxbio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenxbio are associated (or correlated) with Celldex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celldex Therapeutics has no effect on the direction of Regenxbio i.e., Regenxbio and Celldex Therapeutics go up and down completely randomly.

Pair Corralation between Regenxbio and Celldex Therapeutics

Given the investment horizon of 90 days Regenxbio is expected to under-perform the Celldex Therapeutics. In addition to that, Regenxbio is 1.36 times more volatile than Celldex Therapeutics. It trades about -0.13 of its total potential returns per unit of risk. Celldex Therapeutics is currently generating about -0.16 per unit of volatility. If you would invest  2,454  in Celldex Therapeutics on November 27, 2024 and sell it today you would lose (208.00) from holding Celldex Therapeutics or give up 8.48% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Regenxbio  vs.  Celldex Therapeutics

 Performance 
       Timeline  
Regenxbio 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Regenxbio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Celldex Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Celldex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Regenxbio and Celldex Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regenxbio and Celldex Therapeutics

The main advantage of trading using opposite Regenxbio and Celldex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenxbio position performs unexpectedly, Celldex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celldex Therapeutics will offset losses from the drop in Celldex Therapeutics' long position.
The idea behind Regenxbio and Celldex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges